Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
1
GEHC Quote, Financials, Valuation and Earnings
Last price:
$74.26
Seasonality move
:
-9.63%
Day range:
$75.56 - $78.37
52-week range:
$57.65 - $89.77
Dividend yield:
0.18%
P/E ratio:
16.93x
P/S ratio:
1.71x
P/B ratio:
3.39x
Volume:
3.9M
Avg. volume:
3.5M
1-year change:
-9.03%
Market cap:
$35.1B
Revenue:
$20.6B
EPS (TTM):
$4.55
Analysts' Opinion
-
Consensus RatingGE Healthcare Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $93.25, GE Healthcare Technologies, Inc. has an estimated upside of 20.93% from its current price of $77.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $75.00 representing 100% downside risk from its current price of $77.11.
Fair Value
-
According to the consensus of 18 analysts, GE Healthcare Technologies, Inc. has 20.93% upside to fair value with a price target of $93.25 per share.
GEHC vs. S&P 500
-
Over the past 5 trading days, GE Healthcare Technologies, Inc. has underperformed the S&P 500 by -7.47% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
GE Healthcare Technologies, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GE Healthcare Technologies, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter GE Healthcare Technologies, Inc. reported revenues of $5.7B.
Earnings Growth
-
GE Healthcare Technologies, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter GE Healthcare Technologies, Inc. reported earnings per share of $1.29.
Enterprise value:
41.3B
EV / Invested capital:
1.96x
Price / LTM sales:
1.71x
EV / EBIT:
14.28x
EV / Revenue:
2.00x
PEG ratio (5yr expected):
3.46x
EV / Free cash flow:
27.45x
Price / Operating cash flow:
23.45x
Enterprise value / EBITDA:
11.90x
Gross Profit (TTM):
$8.2B
Return On Assets:
6.15%
Net Income Margin (TTM):
10.44%
Return On Equity:
22.05%
Return On Invested Capital:
10.84%
Operating Margin:
15.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $19.6B | $19.7B | $20.6B | $5.3B | $5.7B | |
| Gross Profit | $7.9B | $8.2B | $8.2B | $2.3B | $2.3B | |
| Operating Income | $2.5B | $2.9B | $2.9B | $904M | $900M | |
| EBITDA | $3.1B | $3.5B | $3.5B | $1B | $1B | |
| Diluted EPS | $3.03 | $4.34 | $4.55 | $1.57 | $1.29 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.5B | $7.8B | $9B | $9.5B | $12.1B | |
| Total Assets | $26.3B | $27.5B | $32.5B | $33.1B | $36.9B | |
| Current Liabilities | $6.8B | $7.2B | $9B | $9.6B | $9.1B | |
| Total Liabilities | $9.4B | $17.9B | $25.1B | $24.4B | $26.3B | |
| Total Equity | $16.9B | $9.6B | $7.3B | $8.7B | $10.6B | |
| Total Debt | $327M | $8.5B | $8.7B | $7.8B | $9.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.1B | $2B | $2B | $913M | $1.1B | |
| Cash From Investing | -$558M | -$914M | -$1B | -$240M | -$269M | |
| Cash From Financing | -$478M | -$573M | $617M | -$1.3B | -$293M | |
| Free Cash Flow | $1.7B | $1.6B | $1.5B | $811M | $916M | |
GEHC
Sector
Market Cap
$35.1B
$25.5M
Price % of 52-Week High
85.9%
49.1%
Dividend Yield
0.18%
0%
Shareholder Yield
0.75%
-1.59%
1-Year Price Total Return
-9.03%
-19.13%
Beta (5-Year)
--
0.492
Dividend yield:
0.18%
Annualized payout:
$0.14
Payout ratio:
2.72%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$81.34
200-day SMA
Buy
Level
$76.84
Bollinger Bands (100)
Sell
Level
75.52 - 84.1
Chaikin Money Flow
Buy
Level
94.7M
20-day SMA
Sell
Level
$81.29
Relative Strength Index (RSI14)
Sell
Level
36.25
ADX Line
Sell
Level
17.84
Williams %R
Buy
Level
-86.5917
50-day SMA
Sell
Level
$82.13
MACD (12, 26)
Sell
Level
-0.50
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
29.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9672)
Sell
CA Score
(Annual)
Level (-0.9217)
Buy
Beneish M-Score
(Annual)
Level (-2.3438)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.0061)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Stock Forecast FAQ
In the current month, GEHC has received 11 Buy ratings 6 Hold ratings, and 1 Sell ratings. The GEHC average analyst price target in the past 3 months is $93.25.
-
Where Will GE Healthcare Technologies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that GE Healthcare Technologies, Inc. share price will rise to $93.25 per share over the next 12 months.
-
What Do Analysts Say About GE Healthcare Technologies, Inc.?
Analysts are divided on their view about GE Healthcare Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GE Healthcare Technologies, Inc. is a Sell and believe this share price will drop from its current level to $75.00.
-
What Is GE Healthcare Technologies, Inc.'s Price Target?
The price target for GE Healthcare Technologies, Inc. over the next 1-year time period is forecast to be $93.25 according to 18 Wall Street analysts, 11 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is GEHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GE Healthcare Technologies, Inc. is a Buy. 11 of 18 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GEHC?
You can purchase shares of GE Healthcare Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GE Healthcare Technologies, Inc. shares.
-
What Is The GE Healthcare Technologies, Inc. Share Price Today?
GE Healthcare Technologies, Inc. was last trading at $74.26 per share. This represents the most recent stock quote for GE Healthcare Technologies, Inc.. Yesterday, GE Healthcare Technologies, Inc. closed at $77.11 per share.
-
How To Buy GE Healthcare Technologies, Inc. Stock Online?
In order to purchase GE Healthcare Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GEHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GEHC
Sector
P/E ratio
16.93x
22.36x
PEG ratio
3.46x
-0.01x
P/B ratio
3.39x
1.77x
Price / LTM sales
1.71x
1.50x
Growth Metrics
GEHC
Sector
Revenue growth
7.13%
3.33%
Earnings growth
-17.95%
12%
Revenue (5-year growth)
3.74%
6.38%
Earnings forecast
$1.40
-$0.20
Profitability
GEHC
Sector
Profitability FY 2025
$8.2B
$2.6M
Return on invested capital
10.84%
-33.43%
Return on assets
6.15%
-29.79%
Return on equity
22.05%
-39.5%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
Apr
29
Estimated Next Earnings Date
May
6
Balance Sheet
GEHC
Sector
Total cash
$4.5B
$24.1M
Short term investments
--
$23.2M
Total assets
$36.9B
$69.8M
Long term debt
$9.8B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 28x
Alerts
Buy
78
BNAI alert for Mar 6
Brand Engagement Network, Inc. [BNAI] is up 16.33% over the past day.
Sell
30
MRVL alert for Mar 6
Marvell Technology, Inc. [MRVL] is up 18.6% over the past day.
Sell
43
IOT alert for Mar 6
Samsara, Inc. [IOT] is up 19.54% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
